braz j infect dis.2014;18(6):693–695
The Brazilian Journal of
INFECTIOUS DISEASES
w w w . e l s e v i e r . c o m / l o c a t e / b j i d
Letter to the Editor
Emergence of VanB phenotype-vanA genotype Enterococcus faecium clinical isolate in Bulgaria
DearEditor,
VanA glycopeptide resistance is characterized by acquired inducible resistance to both vancomycin and teicoplanin, whereas the VanB phenotype is characterized by variable levels of resistance to vancomycin but susceptibility to teicoplanin.1 Herewereportavancomycin-resistantEntero- coccus faecium (VREFm) strain with VanB phenotype-vanA genotypeincongruence.
In the course of antimicrobial susceptibility testing of all Enterococcus spp. isolates, we identified a VREFm strain (BG139/2013)exhibitinghigh-levelresistancetovancomycin (MIC>256g/mL)and susceptibilitytoteicoplanin (4g/mL) accordingtotheClinicalandLaboratoryStandardsInstitute 2013recommendations,hence havingtheVanBphenotype.
BG139/2013strainwasisolatedon22February2013fromthe blood ofa male patient aged37 years ata Department of Nephrologyand DialysisinGabrovo,Bulgaria.Speciesiden- tificationwasdonebytheVITEK2system(bioMérieux)and confirmedusingmultiplexpolymerasechainreaction(PCR) aspreviouslydescribed.2
Antimicrobial susceptibility testing was performed by the Etest (LIOFILCHEM). BG139/2013 showed high- level gentamicin resistance; resistance toward ampicillin (MIC>256g/mL), erythromycin (>256), tetracycline (24), ciprofloxacin (>32); and susceptibility tolinezolid (1.5) and chloramphenicol(1.5).
BacterialDNAwasextractedusingtheISOLATEGenomic DNA Mini Kit (Bioline, UK) according to the manu- facturer’s instructions. The glycopeptide antibiotic resis- tance genes were amplified with specific primers as described before: A1/A2, B1/B23 and vanD-F/vanD-R.4 The primers for the vanA and vanD genes were actualized:
vanAD-F 5-GARGAYGGMWSCATMCARGGY-3 and vanAD-R 5-MGTRAAWCCNGGCAKRGTRTT-3.Each25-LPCRmixture consistedof3LoftemplateDNA;a0.1Mofeachprimer;
12.5Lof MyTaq PCRmix (Bioline) and 7.5Lof ultrapure 18.2MPCRwater(Bioline).DNAamplificationwasperformed using the followingprotocol: initialdenaturation(95◦C for 5min),followedby35cyclesofdenaturation(95◦Cfor45s),
annealing (51.3–60◦Cfor45s)andextension(72◦Cfor60s), withasinglefinalextensionof7minat72◦C.Forprimermodi- ficationandphylogeneticanalysesweusedtheGenBankNCBI (National Center for Biotechnology Information) sequence database:FJ545640,JN207933,JN207928,JN207930,EF206284, X56895 (VanA strains); AY665551, U35369, AF310956 and AY145441 (VanB);AF175293,AF153050,AF130997,AY489045, AY082011 and AF277571 (VanD). The sequence reactions and phylogenetic analyses were performed as previously described.5
A630bpPCRproductwasyieldedonlywiththe vanAD- F/vanAD-Rprimerpairatanannealingtemperatureof51.3◦C.
After sequencing, the data for the phylogenetic analysis consistedofa450nucleotidesfragment, or150aminoacid (aa)residues,including125–274aaofvanA.Thepredictedaa sequenceoftheBG139/2013isolatewas100%identicaltothe knownvanAsequences(GenBankaccessionnoAAW56079.1 andAGU36307.1).ThealignmentwithJN207933,JN207928and JN207930 showed that our isolate had a non-synonymous nucleotide mutation leading tothe substitution ofalanine withvalineinposition227intheaminoacidchain.Thephy- logenetictreeshowedthatBG139/2013isolategroupstogether withclustervanAgeneisolatesofE.faecium(Fig.1).
TheVanA phenotyperesistance isdetermined bygenes locatedontransposonTn1546,whichincludesthevanRSreg- ulatorysystemthatactivatesthetranscriptionofresistance genes(vanHAXYZ).6 Thestudiedgenefragmentmakesupa part ofthe protein active site and was identified as vanA genotype in thephylogenetic analysis.On the other hand, BG139/2013hadVanBphenotype.Arelationhasbeenreported betweenanimpairment ofthe responsetoteicoplanin(i.e.
low-levelteicoplaninresistance)andaminoacidsubstitutions duetothreepointmutationsintheN-terminalregionofvanS.6 Thus,thesubstitutionfoundinposition227seemstobeunre- latedtothediscrepancybetweenthephenotypeandgenotype.
Thisdiscrepancycouldmostprobablybeattributedtonon- synonymousmutationsintheN-terminalregionofvanS.
Inconclusion,furtherstudiesonthegenesresponsiblefor the phenotyperesistanceofthe BG139/2013isolate,andon vanSinparticular,areneeded.Toourknowledge,thestudied
694
braz j infect dis.2014;18(6):693–695VanB2
VanA VanB
949
1000
0.1
1000
650
474
AY 1000 6655
51VanB U35369V
anB AF310956V
anB2
AF145441VanB2
JN20 7933
VanA
JN207928V anA
JN207930 VanA
BG139/2013
FJ 54564
0V anA EF20628
4VanA X56895VanA
AF175293vanD AF130997v AF anD
153050v AY489045V anXD
anD
AY082011VanD
AF277571V
anD
VanD
Fig.1–Phylogenetictreebasedonalignmentofa150aminoacidpredictedsequencefromisolateBG139/2013withE.
faeciumreferencestrains.ThetreewasconstructedfromalignedaminoacidpositionsinthefinaldatasetusingMUSCLE.
Onethousandbootstrapreplicationswereusedtobuildthephylogenetictree.
VanBphenotype-vanAgenotypeE.faeciumstrainisthefirstof itskindtobeisolatedinBulgaria.
Conflicts of interest
Theauthorsdeclarenoconflictsofinterest.
Acknowledgement
ThisworkwassupportedbyagrantfromtheMedicalUniver- sityofSofia,Bulgaria(CouncilofMedicalScience,projectno.
12/2013,grantno.16/2013).
references
1.ParkIJ,LeeWG,ShinJH,LeeKW,WooGJ.VanBphenotype-vanA genotypeEnterococcusfaeciumwithheterogeneousexpression ofteicoplaninresistance.JClinMicrobiol.2008;46:
3091–3.
2.JacksonCR,Fedorka-CrayPJ,BarrettJB.Useofgenus-and species-specificmultiplexPCRforidentificationofenterococci.
JClinMicrobiol.2004;42:3558–65.
3.NovickiTJ,SchapiroJM,UlnessBK,etal.Convenientselective differentialbrothforisolationofvancomycin-resistant
Enterococcusfromfecalmaterial.JClinMicrobiol.2004;42:
1637–40.
4.PerichonB,ReynoldsP,CourvalinP.VanD-type
glycopeptide-resistantEnterococcusfaeciumBM4339.Antimicrob AgentsChemother.1997;41:2016–8.
5.PopovaR[PhDthesis]Researchonspread,characteristicsand pathogenicfactorsofEscherichiacoliisolatedfromfood.Sofia, Bulgaria:NationalDiagnosticandResearchVeterinary Institute,BulgarianFoodSafetyAgency;2014.
6.HashimotoY,TanimotoK,OzawaY,MurataT,IkeY.Amino acidsubstitutionsintheVanSsensoroftheVanA-type vancomycin-resistantEnterococcusstrainsresultinhigh-level vancomycinresistanceandlow-levelteicoplaninresistance.
FEMSMicrobiolLett.2000;185:247–54.
TanyaStrateva∗,DanielaAtanasova, IvanMitov DepartmentofMedicalMicrobiology,FacultyofMedicine, MedicalUniversityofSofia,Sofia,Bulgaria
IvoSirakov
NationalDiagnosticandResearchVeterinaryInstitute, Sofia,Bulgaria
AntoninaKatrandjieva
MultiprofileHospitalforActiveTreatment“Dr.TotaVenkova”, Gabrovo,Bulgaria
brazj infect dis.2014;18(6):693–695
695
∗Corresponding author at: Department of Medical Microbiol- ogy,FacultyofMedicine,MedicalUniversityofSofia,2Zdrave Street,1431Sofia,Bulgaria.
E-mailaddress:[email protected](T.Strateva).
Received1June2014 Accepted11June2014
1413-8670/©2014ElsevierEditoraLtda.Allrightsreserved.
http://dx.doi.org/10.1016/j.bjid.2014.06.005